Ocular Therapeutix Competitors and Similar CompaniesClear all

Ocular Therapeutix's competitors and similar companies include Mati Therapeutics and Opthea.

	Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.	Mati Therapeutics Mati Therapeutics is a company that develops a non-invasive sustained drug delivery platform.	Opthea Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.
Founding Date	Founding Date 2006	Founding Date 2012	Founding Date 2012
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare medical devices therapy	Tags Healthcare biotech drug development therapy
Locations	Locations Bedford, US HQ Bedford, US Bedford, US	Locations Austin, US HQ Burnaby, CA	Locations South Yarra, AU HQ Toorak, AU
Employees	Employees 16740% increase	Employees N/A	Employees 33
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) N/A	Valuation ($) 711.2 m
Financial
Revenue (est.)	Revenue (est.) $52m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $25k (FY, 2025)
Cost of goods	Cost of goods $6.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $45.4m (FY, 2025)	Gross profit N/A	Gross profit $146k (FY, 2025)
Net income	Net income ($265.9m) (FY, 2025)	Net income N/A	Net income ($162.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 73.3m	Total funding raised $ 1.6m	Total funding raised $ 67.6m

For sources of this data, please see the company profile

Austin, US

Mati Therapeutics is a company that develops a non-invasive sustained drug delivery platform.

South Yarra, AU

Employees

Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.

Financial